Ketorolac Tromethamine

CAS 74103-07-4 10 current records 8 historicalSmall Molecule

Who holds supplier records for Ketorolac Tromethamine? 10 organisations hold a current record for Ketorolac Tromethamine: an active US FDA Type II Drug Master File or a CEP. A further 8 organisations have only historical (inactive) DMF filings. 5 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (6), Spain (1), China (1) and Italy (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Ketorolac Tromethamine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/ketorolac-tromethamine

Reading the evidence

  • 10 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    6 of the 9 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 7 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Ketorolac Tromethamine expires 15 Aug 2029. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (10)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Ketorolac Tromethamine. Country is the organisation's recorded country, not necessarily the manufacturing site.

India6Spain1China1Italy1Country not recorded for 1
Need Ketorolac Tromethamine sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (5)

Certificates of Suitability on the EDQM register for Ketorolac Tromethamine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 6 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
VIYASH SCIENTIFIC LIMITED HyderabadIN
CEP 2015-046 - Rev 02
Ketorolac trometamol
Jul 2026—
DR. REDDY'S LABORATORIES LIMITED HyderabadIN
R1-CEP 2008-069 - Rev 05
Ketorolac trometamol
Aug 2023—
VASUDHA PHARMA CHEM LIMITED HyderabadIN
R1-CEP 2014-369 - Rev 01
Ketorolac trometamol
Mar 2023—
RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A. MilanoIT
R1-CEP 2007-214 - Rev 01
Ketorolac trometamol
Oct 2020—
MSN LABORATORIES PRIVATE LIMITED Rudraram VillageIN
R1-CEP 2008-144 - Rev 03
Ketorolac trometamol
Jun 2019—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (8)

Organisations whose Type II DMFs for Ketorolac Tromethamine are no longer active. These show a past filing, not current supply.

Show all 8 historical records
  • Spain · Inactive DMF 14209 · filed Jun 1999
  • VIRCO BVBA
    Inactive DMF 12782 · filed Dec 1997
  • Czechia · Inactive DMF 12558 · filed Jun 1997
  • Switzerland · Inactive DMF 11799 · filed Jan 1996
  • ABBOTT LABORATORIES CHEMICAL AND AGRICULTURAL PRODUCTS DIV
    Inactive DMF 11736 · filed Nov 1995
  • Argentina · Inactive DMF 11507 · filed May 1995
  • Canada · Inactive DMF 10740 · filed Feb 1994
  • SYNCHEM CHEMICALS PRIVATE LTD
    Inactive DMF 10372 · filed Nov 1993

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (42 listed products contain Ketorolac Tromethamine). The latest listed patent expires 15 Aug 2029. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Ketorolac Tromethamine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201124).

Chemical identity

IUPAC name
2-amino-2-(hydroxymethyl)propane-1,3-diol;5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
Canonical SMILES
C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O.C(C(CO)(CO)N)O
InChIKey
BWHLPLXXIDYSNW-UHFFFAOYSA-N
Synonyms
Acular, Acular ls, Acular preservative free, Acuvail, Dolac, Ketorolac (+/-)-form tromethamine salt, Ketorolac trometamol, Ketorolac tromethamine, Ketorolac tromethamine component of omidria, Lixidol, NSC-758637, Sprix

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Cyclooxygenase Inhibitor; Nonsteroidal Anti-inflammatory Drug
Mechanism of action
Cyclooxygenase Inhibitors
Chemical structure
Non-Steroidal

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Ketorolac Tromethamine?

10 organisations hold an active US FDA Type II Drug Master File or a CEP for Ketorolac Tromethamine: Shandong New Time Pharmaceutical Co Ltd, Dr. Reddy's Laboratories Ltd. (India), MSN Laboratories Private Limited (India), VASUDHA PHARMA CHEM LTD (India), Viyash Scientific Ltd (India), CHROMO LABORATORIES INDIA PRIVATE LTD (India), Emcure Pharmaceuticals Limited (India) and QUIMICA SINTETICA SA (Spain), and 2 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Ketorolac Tromethamine Drug Master Files are active?

Shandong New Time Pharmaceutical Co Ltd (DMF 22413, 37481), Dr. Reddy's Laboratories Ltd. (DMF 14603), MSN Laboratories Private Limited (DMF 21693), VASUDHA PHARMA CHEM LTD (DMF 29015), Viyash Scientific Ltd (DMF 26870), CHROMO LABORATORIES INDIA PRIVATE LTD (DMF 40725), Emcure Pharmaceuticals Limited (DMF 29840) and QUIMICA SINTETICA SA (DMF 11980) and 1 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Ketorolac Tromethamine records mean?

8 organisations have only inactive Type II DMFs for Ketorolac Tromethamine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Ketorolac Tromethamine have a European Certificate of Suitability?

Yes. 5 organisations hold a valid CEP for Ketorolac Tromethamine on the EDQM register, including VIYASH SCIENTIFIC LIMITED Hyderabad (IN), DR. REDDY'S LABORATORIES LIMITED Hyderabad (IN), VASUDHA PHARMA CHEM LIMITED Hyderabad (IN), RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A. Milano (IT) and MSN LABORATORIES PRIVATE LIMITED Rudraram Village (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Ketorolac Tromethamine?

Yes. The latest patent listed for an approved US product containing Ketorolac Tromethamine expires 15 Aug 2029, across 42 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Ketorolac Tromethamine supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Ketorolac Tromethamine?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.